12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus.

Clin Pharmacol · 2018 · PMC6186903 · PMID 30349407

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantno p-value reported

In these patients, we found a significant reduction in body weight (−1.95 kg) and BMI (−0.69 kg/m 2 ) and an almost significant decrease in waist circumference.

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.